Skip to main content

Table 2 Outcome of MH cases. Values are number (proportion)

From: Malignant hyperthermia when dantrolene is not readily available

 

Survived

Death

total outcome between 1985 and 2010 (n = 61)

28 (45.9%)

33 (54.1%)

total outcome between 2011 and 2019 (n = 31)

22 (71.0%)

9 (29.0%)

outcome between 1985 and 2010 without dantrolene (n = 59)

26 (44.1%)

33 (55.9%)

outcome between 2011 and 2019 without dantrolene (n = 25)

16 (64.0%)

9 (36.0%)